Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
mAb Beta-55
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-29
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb 58
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-54
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb 253
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-53
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-47
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-40
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
mAb Beta-56
Potential treatment - pre-clinical evidence Experimental Antiviral Jan/04/2022
ChAdOx1 nCoV-19
Emergency use authorization Experimental Vaccine Jan/04/2022
Budesonide
Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/31/2021
hrsACE2
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
BRII-198
Potential treatment - theoretical effect Experimental Antiviral Dec/23/2021
BRII-196
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
NK cells
Potential treatment - theoretical effect Used to treat other disease Antiviral Dec/23/2021
BBIBP-CorV
Potential treatment - clinical evidence Experimental Vaccine Dec/23/2021
S2N12
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
S2X324
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
S2H97
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021
S2X259
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/23/2021